EUVIMEDEUVIMED entdecken
Crossref

Development of Dasatinib Loaded Self-Micro Emulsifying Drug Delivery System: In-Vitro Characterization

Nitin V. Kokare, Rohit R. Shah

International Journal of Drug Delivery Technology · 14.07.2026 · 16 (64s)

DOI: 10.25258/ijddt.16.64s.202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.07.2026. Verfasst von Nitin V. Kokare und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dasatinib is a BCS Class II tyrosine kinase inhibitor indicated for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. However, its poor aqueous solubility and pHdependent absorption significantly limit its oral bioavailability. The present study aimed to develop and characterize a Dasatinib-loaded Self-Micro Emulsifying Drug Delivery System (SMEDDS) to enhance solubility and improve invitro anticancer activity. Solubility screening facilitated the selection of Capryol 90 as the oil phase, Tween 40 as the surfactant, and Transcutol HP as the co-surfactant. A pseudo-ternary phase diagram was constructed to identify the optimal microemulsion region. The optimized SMEDDS formulation was prepared by dissolving Dasatinib in the preconcentrate mixture and evaluated for cytotoxic activity using the MTT assay against the HL-60 human leukemia cell line. The results demonstrated dose-dependent inhibition for all tested samples. The standard drug, 5-Fluorouracil, exhibited an IC50 value of 33.91 µg/ml, while the Dasatinib API showed an IC50 of 44.29 µg/ml. Notably, the SMEDDS formulation exhibited improved cytotoxic activity with an IC50 value of 38.56 µg/ml, indicating enhanced therapeutic potential compared to the pure drug. The enhanced performance of the SMEDDS may be attributed to improved solubilization and cellular uptake. Overall, the developed SMEDDS formulation represents a promising lipid-based strategy for enhancing the solubility and in-vitro anticancer efficacy of Dasatinib.

Zitieren

APA

Kokare, N. V., & Shah, R. R. (2026). Development of Dasatinib Loaded Self-Micro Emulsifying Drug Delivery System: In-Vitro Characterization. International Journal of Drug Delivery Technology, 16(64s). https://doi.org/10.25258/ijddt.16.64s.202

Vancouver

Kokare NV, Shah RR. Development of Dasatinib Loaded Self-Micro Emulsifying Drug Delivery System: In-Vitro Characterization. International Journal of Drug Delivery Technology. 2026;16(64s). doi:10.25258/ijddt.16.64s.202

BibTeX
@article{Kokare2026,
  author = {Kokare, Nitin V. and Shah, Rohit R.},
  title = {Development of Dasatinib Loaded Self-Micro Emulsifying Drug Delivery System: In-Vitro Characterization},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {64s},
  doi = {10.25258/ijddt.16.64s.202}
}
Kostenlos starten →